A Case of Altered Mental Status, Not Otherwise Specified
Neurol 89:e154-e158, Swor, D.E.,et al, 2017
Antibiotic-Associated Encephalopathy
Neurol 86:963-971, Bhattacharyya, S.,et al, 2016
Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011
Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023
A 48-Year-Old Woman with 6 Months of Vivid Visual Hallucinations
Neurol 99:166-171, Kizza, J.,et al, 2022
Drug-Related Demyelinating Syndromes: Understanding Risk Factors, Pathophysiological Mechanisms and Magnetic Resonance Imaging Findings
Mult Scler Rel Dis 55:103146, Rimkus, C.M.,et al, 2021
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Cerebellar Hippocampal and Basal Nuclei Transient Edema with Restricted Diffusion (CHANTER) Syndrome
Neurocrit Care 31:228-296, Jasne, A.S.,et al, 2019
Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy
Neurol 91:e359-e363, Rauer,S.,et al, 2018
Intracranial Meningeal Enhancement Characterization
Rev Colomb Radiol 28:4709-4716, Mera, J.L.C.,et al, 2017
Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and Manifestations
RadioGraphics 37:562-576, Starkey, J.,et al, 2017
Delayed Onset of Progressive Chorea After Acute Basal Ganglia Injury
Mov Disord 28:585-587, Virmani, T.,et al, 2013
Multimodal Imaging of Reversible Cerebral Vasoconstriction Syndrome: A Series of 6 Cases
AJNR 33:1403-1410, Marder, C.P.,et al, 2012
Tumefactive Multiple Sclerosis Lesions under Fingolimod Treatment
Neurol 79:2000-2002,1942, Visser, F.,et al, 2012
Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia
Clin Lymphoma Myeloma Leuk 12:164-179, Lopes da Silva, R., 2012
Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008
Delayed Leukoencephalopathy with Stroke-Like Presentation in Chemotherapy Recipients
JNNP 79:535-539, Baehring,J.M. &Fulbright,R.K., 2008
Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008
Narrative Review: Reversible Cerebral Vasoconstriction Syndromes
Ann Intern Med 146:34-44, Calabrese,L.H.,et al, 2007
Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis
Mod Rheumatol 17-72-74, Yamamoto, M.,et al, 2007
The Clinical and Radiological Spectrum of Reversible Cerebral Vasoconstriction Syndrome. A Prospective Series of 67 Patients
Brain 130:3091-3101, Ducros, A.,et al, 2007
Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006
Leukoencephalopathy Induced by Levamisole Alone for the Treatment of Recurrent Aphthous Ulcers
Neurol 67:1065-1067, Liu,J.M.,et al, 2006
Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine
AJNR 26:695-701,687, Tardieu,M.,et al, 2005
Cerebral Vasoconstriction and Stroke After Use of Serotonergic Drugs
Neurol 58:130-133, Singhal,A.B.,et al, 2002
Brown-Sequard Syndrome After Esophageal Sclerotherapy and Crack Cocaine Abuse
Neurol 58:1129-1130, Mueller,D. &Gilden,D.H., 2002
Toxic Leukoencephalopathy
NEJM 345:425-432, Filley,C.M. &Kleinschmidt-DeMasters,B.K., 2001
Onset of Multiple Sclerosis Associated With Anti-TNF Therapy
Neurol 57:1885-1888, Sicotte,N.L. &Voskuhl,R.R., 2001
Tremor Caused by Trimethoprim-Sulfamethoxazole in a Patient with AIDS
Neurol 48:537-538, VanGerpen,J.A., 1997
Trimethoprim and Sulfonamide-Associated Meningoencephalitis with MRI Correlates
Neurol 46:556-558, Blumenfeld,H.,et al, 1996
Investigation of Muscle Disease
JNNP 60:256-274, Mastaglia,F.L.&Laing,N.G., 1996
Multifocal Inflammatory Leukoencephalopathy Associated with Levamisole Therapy
Neurol 45:374-376, Kimmel,D.W.,et al, 1995
Nocturnal Blood Pressure Dip in Stroke Survivors, A Pilot Study
Stroke 26:1373-1378, Nakamura,K.,et al, 1995
Neurotox of Antimicrob & Antimalarial Agents
In Intox of Nervous System, Part II, Handbk Clin Neurol, Elsevier Science 21 (65) :471., Moorhouse,D.F.,et al, 1995
Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy
Ann Neurol 38:687-691, Papazian,O.,et al, 1995
Cerebral Infarction Following Intravenous Immunoglobulin Therapy for Myasthenia Gravis
Neurol 44:1180-1181, Steg,R.E.&Lefkowitz,D.M., 1994
Worsening of Neurologic Syndrome in Patients with Wilson's Disease with Initial Penicillamine Therapy
Arch Neurol 44:490-493, Brewer,G.J.,et al, 1994
Neuropathologic Correlated of Persistent Neurologic Deficit in Lithium Intoxication
Ann Neurol 36:928-931, Schneider,J.A.&Mirra,S.S., 1994
Reversible Neurologic Toxicity with Fludarabine Phosphate for Mycosis Fungiodes & Chronic Lymphocytic Leukemia
Ann Int Med 118:114-116, Cohen,R.B.,et al, 1993
Stroke Associated with Ephedrine Use
Neurol 43:1313-1316, Bruno,A.,et al, 1993
Cyclosporine-Related Central Nervous System Toxicity in Cardiac Transplantation
NEJM 323:420-421, Hughes,R.L., 1990
Central Nervous System Toxicity After Liver Transplantation, The Role of Cyclosporine & Cholesterol
NEJM 317:861-866, DeGroen,P.C.,et al, 1987
The Neurotoxicity of Antibacterial Agents
Ann Int Med 101:92-104, Snavely,S.R.,et al, 1984
Permanent Neurological Deficits Due to Lithium Toxicity
Ann Neurol 13:453-455, Apte,S.N.,et al, 1983
Persisting Neurologic Sequelae of Lithium Carbonate Therapy
Arch Neurol 40:747-751, MacDonaldson,I.,et al, 1983
Cerebellar Degeneration Due to Chronic Phenytoin Therapy
Ann Neurol 7:18-23, McLain,L.W.,et al, 1980
Nervous System Toxicity of Chemo Agents
Young, DF, in Vinken PJ, Bruyn GW, Handbook of Clin Neurol, North-Holland Publ Co, Amster, Vol 39, 1, 80, p 104, 1980
Acute Transitory Cerebellar Dysfunction Associated with Piperazine Adipate
Arch Neurol 36:180-181, Berger,J.R.,et al, 1979
Acute Meningoencephalitis Assoc. with Isoiazid Admin
JAMA 235:1141, Garagusi,V.F.,et al, 1976